Company Registration No. 11023249 (England and Wales)
Ellipse Medical Limited
Unaudited accounts
for the year ended 31 December 2025
Ellipse Medical Limited
Unaudited accounts
Contents
Ellipse Medical Limited
Company Information
for the year ended 31 December 2025
Company Number
11023249 (England and Wales)
Registered Office
114 Power Road
Unit 3.1
London
W4 5PY
Ellipse Medical Limited
Statement of financial position
as at 31 December 2025
Cash at bank and in hand
111,369
115,426
Creditors: amounts falling due within one year
-
(7,076)
Net current assets
111,836
108,350
Total assets less current liabilities
111,836
108,350
Creditors: amounts falling due after more than one year
-
(689,436)
Net assets/(liabilities)
111,836
(581,086)
Called up share capital
50,000
50,000
Profit and loss account
61,836
(631,086)
Shareholders' funds
111,836
(581,086)
For the year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 3 June 2026 and were signed on its behalf by
R. Blood
Director
Company Registration No. 11023249
Ellipse Medical Limited
Notes to the Accounts
for the year ended 31 December 2025
Ellipse Medical Limited is a private company, limited by shares, registered in England and Wales, registration number 11023249. The registered office is 114 Power Road, Unit 3.1, London, W4 5PY.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
The directors intend to apply to strike the company off the register within 12 months of the balance sheet date. Accordingly, the financial statements have been prepared on a basis other than going concern.
4
Intangible fixed assets
Goodwill
At 31 December 2025
780,626
At 31 December 2025
780,626
Amounts falling due within one year
Ellipse Medical Limited
Notes to the Accounts
for the year ended 31 December 2025
6
Creditors: amounts falling due within one year
2025
2024
7
Creditors: amounts falling due after more than one year
2025
2024
Amounts owed to group undertakings and other participating interests
-
437,936
Allotted, called up and fully paid:
50,000 Ordinary shares of £1 each
50,000
50,000
9
Transactions with related parties
During the year, the company entered into a transaction with a connected company, Ellipse A/S, under common control.
A balance of £693,233 due to Ellipse A/S was formally waived during the year.
The transaction was undertaken on terms agreed between the parties.
At the balance sheet date, no amounts remained outstanding (2025: £689,436 payable).
The ultimate holding company is Syneron Medical Ltd, a company registered in Israel.
11
Average number of employees
During the year the average number of employees was 0 (2024: 0).